Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72


Coronary revascularization for patients with diabetes: updated data favor coronary artery bypass grafting.

Ellis SG.

J Am Coll Cardiol. 2013 Feb 26;61(8):817-9. doi: 10.1016/j.jacc.2012.12.003. No abstract available.


Reply: To PMID 23428214.

Kamalesh M, Sharp T.

J Am Coll Cardiol. 2013 Jun 18;61(24):2492-3. doi: 10.1016/j.jacc.2013.03.017. Epub 2013 Mar 28. No abstract available.


"Cherry-picking" patients for randomized, controlled trials--reliving the past….

Farooq V, Serruys PW.

J Am Coll Cardiol. 2013 Jun 18;61(24):2492. doi: 10.1016/j.jacc.2013.03.018. Epub 2013 Mar 28. No abstract available.


Influence of diabetes mellitus on long-term (five-year) outcomes of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization.

Kim YG, Park DW, Lee WS, Park GM, Sun BJ, Lee CH, Hwang KW, Cho SW, Kim YR, Song HG, Ahn JM, Kim WJ, Lee JY, Kang SJ, Lee SW, Kim YH, Lee CW, Park SW, Han S, Jung SH, Choo SJ, Chung CH, Lee JW, Park SJ.

Am J Cardiol. 2012 Jun 1;109(11):1548-57. doi: 10.1016/j.amjcard.2012.01.377. Epub 2012 Mar 16.


Long-term outcome of stents versus bypass surgery in diabetic and nondiabetic patients with multivessel or left main coronary artery disease: a pooled analysis of 5775 individual patient data.

Park DW, Kim YH, Song HG, Ahn JM, Kim WJ, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Yun SC, Chung SH, Choo SJ, Chung CH, Lee JW, Park SJ.

Circ Cardiovasc Interv. 2012 Aug 1;5(4):467-75. doi: 10.1161/CIRCINTERVENTIONS.112.969915. Epub 2012 Aug 7.


Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.

Luo Y, Yu X, Chen F, Du X, He J, Gao Y, Zhang X, Zhang Y, Ren X, Lv S, Ma C.

Coron Artery Dis. 2012 Aug;23(5):322-9. doi: 10.1097/MCA.0b013e3283564961.


Comparison of one-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease and acute coronary syndromes (from the CUSTOMIZE Registry).

Caggegi A, Capodanno D, Capranzano P, Chisari A, Ministeri M, Mangiameli A, Ronsivalle G, Ricca G, Barrano G, Monaco S, Di Salvo ME, Tamburino C.

Am J Cardiol. 2011 Aug 1;108(3):355-9. doi: 10.1016/j.amjcard.2011.03.050. Epub 2011 May 3.


Increased early postoperative morbidity with off-pump coronary artery bypass grafting surgery in patients with diabetes.

Vermes E, Demaria RG, Martineau R, Cartier R, Pellerin M, Hébert Y, Bouchard D, Pagé P, Carrier M, Perrault LP.

Can J Cardiol. 2004 Dec;20(14):1461-5.


Impact of completeness of revascularization on long-term cardiovascular outcomes in patients with type 2 diabetes mellitus: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D).

Schwartz L, Bertolet M, Feit F, Fuentes F, Sako EY, Toosi MS, Davidson CJ, Ikeno F, King SB 3rd.

Circ Cardiovasc Interv. 2012 Apr;5(2):166-73. doi: 10.1161/CIRCINTERVENTIONS.111.963512. Epub 2012 Apr 10.


Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting.

Thourani VH, Weintraub WS, Stein B, Gebhart SS, Craver JM, Jones EL, Guyton RA.

Ann Thorac Surg. 1999 Apr;67(4):1045-52.


Outcomes of coronary revascularization (percutaneous or bypass) in patients with diabetes mellitus and multivessel coronary disease.

Hee L, Mussap CJ, Yang L, Dignan R, Kadappu KK, Juergens CP, Thomas L, French JK.

Am J Cardiol. 2012 Sep 1;110(5):643-8. doi: 10.1016/j.amjcard.2012.04.043. Epub 2012 May 25.


Myocardial revascularization in patients with end-stage renal disease: comparison of percutaneous transluminal coronary angioplasty and coronary artery bypass grafting.

Ivens K, Gradaus F, Heering P, Schoebel FC, Klein M, Schulte HD, Strauer BE, Grabensee B.

Int Urol Nephrol. 2001;32(4):717-23.


Propensity case-matched analysis of off-pump coronary artery bypass grafting in patients with atheromatous aortic disease.

Sharony R, Grossi EA, Saunders PC, Galloway AC, Applebaum R, Ribakove GH, Culliford AT, Kanchuger M, Kronzon I, Colvin SB.

J Thorac Cardiovasc Surg. 2004 Feb;127(2):406-13.


Therapies for type 2 diabetes and coronary artery disease.

Bertoldi EG, Weinert LS, Polanczyk CA.

N Engl J Med. 2009 Oct 1;361(14):1408; author reply 1409-10. No abstract available.


Complexity of atherosclerotic coronary artery disease and long-term outcomes in patients with unprotected left main disease treated with drug-eluting stents or coronary artery bypass grafting.

Park DW, Kim YH, Yun SC, Song HG, Ahn JM, Oh JH, Kim WJ, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Park SJ.

J Am Coll Cardiol. 2011 May 24;57(21):2152-9. doi: 10.1016/j.jacc.2011.01.033.


Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.

Kapur A, Hall RJ, Malik IS, Qureshi AC, Butts J, de Belder M, Baumbach A, Angelini G, de Belder A, Oldroyd KG, Flather M, Roughton M, Nihoyannopoulos P, Bagger JP, Morgan K, Beatt KJ.

J Am Coll Cardiol. 2010 Feb 2;55(5):432-40. doi: 10.1016/j.jacc.2009.10.014.

Supplemental Content

Support Center